Cost-Utility Analysis of Eox Drug Regimen Versus Dcf Drug Regimen for the Patients with Advanced Gastric Cancer in Shiraz in 2015
Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.131
https://www.valueinhealthjournal.com/article/S1098-3015(18)32488-4/fulltext
Title :
Cost-Utility Analysis of Eox Drug Regimen Versus Dcf Drug Regimen for the Patients with Advanced Gastric Cancer in Shiraz in 2015
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)32488-4&doi=10.1016/j.jval.2018.07.131
First page :
Section Title :
Open access? :
No
Section Order :
127